Anti-SREBP1 (2A4; Santa Cruz Biotechnology, Inc.), anti-FAS (Cell Signaling Technology, Inc.), anti–Flag M2 (Sigma-Aldrich), anti–β-actin (Sigma-Aldrich), and anti–β-tubulin (Life Technologies) antibodies were purchased in this study. The boron-containing compounds BF175 and BF62 were synthesized and purified according to the method we reported previously (16 (link)).